Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Rubio-Guerra, A. F.
Right arrow Articles by Rubio-Guerra, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rubio-Guerra, A. F.
Right arrow Articles by Rubio-Guerra, A. F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Isosorbide Aerosol: An Option for the Treatment of Hypertensive Crises

Alberto Francisco Rubio-Guerra, MD

German Vargas-Ayala, MD

José Juan Lozano-Nuevo, MD

Jorge Luis Narvaez-Rivera, MD

Leticia Rodríguez-López, MD

Francisco Javier Caballero-González, MD

Alberto Francisco Rubio-Guerra, MD

Plan de San Luis S/N Esq. Bandera Mexico City, C.P. 07330 Mexico

In this study the authors assessed the effectivenes and safety of isosorbide dinitrate aerosol administered through the oral mucosa in 30 adult patients who presented with a hypertensive crisis (mean arterial pressure > 130 mm Hg and evidence of target organ damage). The patients were given a first dose of 1.25 mg of aerosol when they were admitted to the hospital; a second dose was administered 15 minutes later if the mean arterial pressure had not decreased by > 15%. An electrocardiogram (ECG) was obtained for every patient immediately prior to and 30 minutes after administration of the medica tion. Nine patients (30%) had a good response with one dose, whereas 21 patients (70%) required a second dose. All 30 patients had a significant reduction of the arterial blood pressure (187 ± 13/121 ± 6.6 to 153 ± 15.3/92.3 ± 7.6 mm Hg; p < 0.005) as well as of the mean arterial pressure (136.6 ±8 to 109.5 ±7 mm Hg; p<0.005) in a period of 30 minutes. No adverse effects, rebound hypertension, or severe hypotension were observed. These figures remained under control for 6 hours. Two of the patients had angina pectoris at admission and their ECG showed subepicardial ischemia, both of which disappeared with the medication. A second ECG appeared normal. A reduction of 14% in heart rate was obtained (95 ± 15 to 82 ± 14 beats per minute; p < 0.005) . These observations suggest that isosorbide dinitrate aerosol is an effective and safe alternative for the treatment of patients with hypertensive crises.

Angiology, Vol. 50, No. 2, 137-142 (1999)
DOI: 10.1177/000331979905000207


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement